Jarislowsky, Fraser LTD Embecta Corp. Transaction History

Jarislowsky, Fraser LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Sep 27, 2024	BUY	$25.29 - $35.48 $238,004 - $333,902	9,411 New	9,411 $238,000
Q4 2022 Feb 10, 2023	SELL	$25.29 - $35.48 $50,453 - $70,782	-1,995 Reduced 17.49%	9,411 $238,000
Q3 2022 Nov 07, 2022	SELL	$24.0 - $33.42 $436,632 - $608,010	-18,193 Reduced 61.46%	11,406 $328,000
Q2 2022 Jul 27, 2022	BUY	$24.78 - $33.36 $733,463 - $987,422	29,599 New	29,599 $749,000

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Jarislowsky, Fraser LTD, based on Form 13F filings with the SEC.

Stay updated on Jarislowsky, Fraser LTD with notifications on news.